Codes / ICD10CM / F13.23

F13.23 Sedative, hypnotic or anxiolytic dependence with withdrawal

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Sedative, Hypnotic, or Anxiolytic Dependence with Withdrawal (ICD-10 Code: F13.23)

Summary

This condition involves a pattern of dependence on sedative, hypnotic, or anxiolytic substances, accompanied by withdrawal symptoms when use is reduced or stopped. It is characterized by physical or psychological reliance on these drugs, often prescribed for anxiety or sleep disorders, and withdrawal symptoms that occur as the body adjusts to the absence of the substance.

Causes

The condition typically develops from prolonged use or misuse of sedative, hypnotic, or anxiolytic medications. It may begin with therapeutic use and progress to dependence due to factors like increased tolerance, continued use despite negative consequences, or self-medication for underlying mental health issues. Abrupt discontinuation or dose reduction can trigger withdrawal symptoms.

Risk Factors

  • Contributing factors include a history of substance abuse, co-occurring mental health disorders, chronic stress, and environments where these substances are easily accessible. Genetic predispositions and prior exposure to similar drugs may also increase risk.

Symptoms

  • Symptoms include a strong desire to use the substance, difficulty controlling use, increased tolerance, withdrawal symptoms when not using, and continued use despite physical or psychological harm. Withdrawal symptoms may include anxiety, insomnia, tremors, or seizures.

Diagnosis

Diagnosis is based on a clinical evaluation, including patient history, symptom assessment, and standardized criteria for substance dependence and withdrawal. Healthcare providers may use tools to assess the severity and duration of symptoms.

Treatment Options

Treatments often include behavioral therapies, counseling, and support groups. Medication-assisted treatment may involve tapering the substance under medical supervision to manage withdrawal symptoms safely. In some cases, alternative medications may be used to stabilize the patient during recovery.

Prognosis and Follow-Up

Prognosis varies depending on the severity of dependence, co-occurring conditions, and adherence to treatment. Regular follow-up is essential to monitor progress, adjust treatment plans, and address any relapse risks. Long-term recovery often requires ongoing support and lifestyle modifications.

Complications

Complications may include severe withdrawal symptoms (e.g., seizures), relapse, co-occurring mental health disorders, and social or occupational impairment. Untreated withdrawal can lead to life-threatening conditions, such as delirium tremens.

Lifestyle & Prevention

Lifestyle modifications may include avoiding triggers, engaging in stress-reduction techniques, and maintaining a support network. Prevention strategies focus on using these medications only as prescribed, avoiding misuse, and seeking help early if dependence is suspected.

When to Seek Professional Help

Seek professional help if withdrawal symptoms are severe, unmanageable, or accompanied by suicidal thoughts. Immediate medical attention is necessary for symptoms like seizures, severe confusion, or difficulty breathing.

Tips for Medical Coders

Document the presence of withdrawal symptoms and their impact on the patient's condition. Ensure clinical notes support the diagnosis, including details on substance use history, withdrawal severity, and treatment interventions. Code F13.23 is specific to dependence with withdrawal; avoid using it if withdrawal is not present.

Book a walkthrough

F13.23 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.